Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.
Bausch & Lomb Inc, Rochester, New York, United States
Bausch & Lomb, Incorporated, Rochester, New York, United States
Bausch & Lomb Incorporated, Rochester, New York, United States
PAREXEL Port Elizabeth, Port Elizabeth, South Africa
PAREXEL Bloemfontein, Bloemfontein, South Africa
PAREXEL George, George, South Africa
Clinical Research Hospital Tokyo, Tokyo, Japan
Kawaguchi Kogyo General Hospital, Saitama, Japan
Tokyo Women's Medical University, Tokyo, Japan
Bausch & Lomb Incorporated, Rochester, New York, United States
Bausch & Lomb, Rochester, New York, United States
Bausch & Lomb, Incorporated, Rochester, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.